Enzymatic Therapy Acquires SneeEze And Renouvelle From EuroPharma

GREEN BAY, Wis.--(BUSINESS WIRE)--March 17, 2005--Enzymatic Therapy has reached an agreement with EuroPharma USA, Inc., for the distribution of SneezeEze(TM) and Renouvelle(R). This announcement tops a long list of recent accomplishments for the manufacturer and distributor of premium nutritional supplements and natural medicines. Within the last few months the company acquired distribution rights for Alluna(TM), the leading natural sleep aid, from Glaxo-SmithKline and earned the highly regarded organic processor certification from the American Food Safety Institute. These three product transactions expand Enzymatic Therapy’s already powerful family of innovative products. Each one addresses a consumer market with a growing demand for natural, safe solutions. Alluna promotes a healthy sleep pattern with safe, non habit-forming ingredients. SneezEze is an over the counter product that relieves allergy and hay fever symptoms with no drowsiness or side effects. Renouvelle debuts as the company’s first cosmetic product and is a luscious, restoring nighttime skin treatment. It’s made from 100% pure, natural plant actives for a healthy, radiant complexion.